We have shown that stool samples from different patients can be pooled at a 1:2 dilution and reliably assayed for Giardia lamblia antigen by a commercial microtiter enzyme-linked immunosorbent assay (ELISA) system (LMD Laboratories, Inc., Carlsbad, Calif.). Laboratories can reduce reagent costs by pooling specimens submitted for the detection of Giardia antigen by ELISA.
Diagnostic microbiology laboratories are increasingly faced with cost constraints. Recent publications (3, 6) have demonstrated that significant cost savings can be achieved by restricting the examination of stool specimens for ova and parasites. Additionally, several researchers (1, 4) have concluded that pooling stool specimens before examination for parasites is economical and reliable. Technologists' time can also be saved by using enzyme-linked immunosorbent assays (ELISAs) for the detection of some parasite antigens. ELISAs are, however, expensive, and the yield is often low. In an attempt to reduce the cost of testing for Giardia antigen, we pooled consecutively isolated stool specimens from different patients before performing an ELISA.
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ted to the University of New Mexico Hospital diagnostic microbiology laboratory from 113 patients were tested individually and pooled at a 1:2 dilution (25-,ul aliquots of two consecutively received specimens in the same test well). All fresh clinical specimens were tested within 7 days of collection.
Routine testing of 144 formalin-fixed stool specimens received over a 4-month period resulted in 11 (7.6%) positive specimens (absorbance range, 0.412 to >3). Two consecutively received specimens were pooled to give a 1:2 dilution.
Eleven of these 72 pooled specimens yielded positive results (absorbance range, 0.356 to 2.575). All positive specimens in combination with a negative specimen gave positive results. No combination of negative specimens gave a positive result. Retesting the individual stool specimens of the 11 positive pooled specimens meant that an additional 22 tests had to be performed.
Previously, over a 19-month period, our laboratory received 2,536 stool specimens for ovum and parasite examination. Only 4.8% were positive for ova or parasites. In addition to instituting utilization controls, we investigated the reliability of pooling stool specimens before testing by an ELISA. Rosenblatt et al. (5) (7) studied the detection of G. lamblia in pooled stool specimens. The sensitivity of microscopic detection in three pooled stool specimens from one patient was 100% compared with the microscopic detection of G. lamblia antigen in three individual specimens from the same patient.
In our testing of pooled stock formalin-fixed stool specimens, 37 of 38 stool specimens positive for G. lamblia by microscopic examination and ELISA remained positive by ELISA when diluted 1:2. When diluted 1:5, 10 of 38 gave absorbance readings in a zone between the negative and positive controls. Pooled specimens giving results in the gray zone should be tested again individually, and a final report should be based on those results. Some repeat testing would have to be performed when a pooled specimen of consecutively isolated stool specimens is determined to be positive. Eleven of 72 pooled clinical specimens received in our laboratory were positive. Retesting the positive pooled specimens individually meant that 22 additional tests had to be performed. This represents a 35% (94/144 = 65%) reduction in testing. Although the repeat testing would involve some additional labor, because the incidence of stool specimens positive for G. lamblia is low, the labor is minimal compared with the cost of the enzyme immunoassay kits.
Pooling of stool specimens from different patients before testing will be controversial. Laboratorians have been trained to carefully keep individual patient specimens apart. There appears to be no inherent reason not to pool specimens unless one speculates that one patient's specimen may have substances that interfere with the test being run. We did not detect any interfering substances in this ELISA. As even more expensive and extremely sensitive tests, like polymerase chain reactions, become commercially available, pooling of different patients' specimens should be investigated as a way to save kit costs. We did not test pooled stool specimens at a 1:3 dilution, although earlier studies (1, 4) demonstrated no loss of sensitivity when three stool specimens from the same patient were combined. Combining three stool specimens from different patients could lead to an even greater saving of reagents. Pooling of consecutively submitted stool specimens diluted 1:2 before testing by an ELISA is a reliable, cost-effective method for detecting Giardia antigen.
